Lenacapavir as pre‐exposure prophylaxis for HIV prevention
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Lenacapavir as Pre‐exposure Prophylaxis for HIV Prevention." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440901/all/Lenacapavir_as_pre‐exposure_prophylaxis_for_HIV_prevention.
Lenacapavir as pre‐exposure prophylaxis for HIV prevention. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440901/all/Lenacapavir_as_pre‐exposure_prophylaxis_for_HIV_prevention. Accessed April 20, 2026.
Lenacapavir as pre‐exposure prophylaxis for HIV prevention. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440901/all/Lenacapavir_as_pre‐exposure_prophylaxis_for_HIV_prevention
Lenacapavir as Pre‐exposure Prophylaxis for HIV Prevention [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 April 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440901/all/Lenacapavir_as_pre‐exposure_prophylaxis_for_HIV_prevention.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lenacapavir as pre‐exposure prophylaxis for HIV prevention
ID - 440901
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440901/all/Lenacapavir_as_pre‐exposure_prophylaxis_for_HIV_prevention
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -

Cochrane Abstracts

